A Trial on Fezolinetant for Vasomotor Symptoms in Men Receiving Androgen Deprivation Therapy (ADT)

NCT07568236 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Vasomotor Symptoms
Prostate Cancer

Interventions

DRUG: Fezolinetant
DRUG: Placebo

Sponsor

Chinese University of Hong Kong